This does not mean a medicine is always unsafe for them, but it does mean the risk-benefit review should be individualized
Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P
And researchers like Greig, Li, and their colleagues have shown that the GLP-1 agonists do reduce brain injury in animal models of stroke, traumatic brain injury, Parkinsons, Alzheimers, and ALS
In EPIC-HR, of 59 PAXLOVID-treated subjects identified with post-treatment viral RNA rebound and with available viral sequence data, treatment-emergent substitutions in Mpro potentially reducing nirmatrelvir activity were detected in 2 (3%) subjects, including E166V in 1 subject and T304I in 1 subject
This guide breaks down everything you need to know about dosing from a 5mg semaglutide vial
Autoimmune disorders such as lupus and rheumatoid arthritis